0001127602-20-022089.txt : 20200724 0001127602-20-022089.hdr.sgml : 20200724 20200724162454 ACCESSION NUMBER: 0001127602-20-022089 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200723 FILED AS OF DATE: 20200724 DATE AS OF CHANGE: 20200724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Benjamin Eric CENTRAL INDEX KEY: 0001731734 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 201047167 MAIL ADDRESS: STREET 1: C/O INSULET CORPORATION STREET 2: 600 TECHNOLOGY PARK DR, SUITE 200 CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-07-23 0001145197 INSULET CORP PODD 0001731734 Benjamin Eric C/O INSULET CORPORATION 100 NAGOG PARK ACTON MA 01720 1 SVP, Innovation and Strategy Common Stock 2020-07-23 4 S 0 6520 210.00 D 8704 D Common Stock 2020-07-23 4 M 0 1396 30.02 A 10100 D Common Stock 2020-07-23 4 M 0 6996 29.26 A 17096 D Common Stock 2020-07-23 4 S 0 8392 210.00 D 8704 D Employee Stock Option (Right to Buy) 30.02 2020-07-23 4 M 0 1396 0 D 2025-07-01 Common Stock 1396 0 D Employee Stock Option (Right to Buy) 29.26 2020-07-23 4 M 0 6996 0 D 2026-02-24 Common Stock 6996 0 D The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. Includes 107 shares acquired under the Insulet Corporation Stock Purchase Plan on May 29, 2020. This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. /s/ John W. Kapples, attorney-in-fact 2020-07-24